Status:

RECRUITING

Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Single-dose

Lead Sponsor:

Stanford University

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

Autism Spectrum Disorder

Eligibility:

All Genders

3-12 years

Phase:

PHASE2

Brief Summary

The goal of this study is to target the neurobiology of restricted and repetitive behaviors in children with autism spectrum disorder using N-acetylcysteine (NAC), a well-tolerated nutritional supplem...

Eligibility Criteria

Inclusion

  • children between 3 years and 12 years 11 months at the time of consent
  • diagnosis of Autism Spectrum Disorder confirmed with the Autism Diagnostic Interview-Revised (ADI-R) and the Autism Diagnostic Observation Schedule-2 (ADOS-2), or Brief Observation of Symptoms of Autism (BOSA), or Childhood Autism Rating Scale- Second Edition (CARS-2).
  • at least moderate Restricted and Repetitive Behaviors severity defined by a Children's Yale-Brown Obsessive Compulsive Scale for children with autism spectrum disorder score ≥ 11,
  • physical development indicative of prepubescence as defined by the criteria for Tanner Stage 1,
  • medically stable,
  • passes MR safety screening (e.g., no metal in the body).

Exclusion

  • presence of known genetic abnormalities associated with Autism Spectrum Disorder (e.g. Fragile X),
  • current or life-time diagnosis of severe psychiatric disorder (e.g., schizophrenia),
  • presence of significant medical problems that would interfere with participation,
  • the inability of at least one caregiver to speak/read English to a sufficient level to complete study requirements and materials,
  • individuals taking antioxidant agents and glutathione prodrugs, or
  • the inability/unwillingness to swallow an agent during the screening visit.

Key Trial Info

Start Date :

February 12 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2027

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT04278898

Start Date

February 12 2021

End Date

January 1 2027

Last Update

August 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stanford University School of Medicine

Stanford, California, United States, 94305